Predicting prostate cancer: Nanotechnology shows promise for more accurate prostate cancer screening and prognosis

A study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments. The prostate-specific antigen (PSA) test was once the recommended screening tool for detecting prostate cancer, but there is now disagreement over the use of this test because it can't predict which men with elevated PSA levels will actually develop an aggressive form of the disease.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1AxFNRP